Durable complete response to PET‐CT driven stereotactic radiation therapy plus pembrolizumab for pleomorphic Pancoast cancer: Case report and literature review | Synapse

⌘+K

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A rare case of Pancoast tumor with complete pathological response after neoadjuvant chemo+immunotherapy and chest wall resection and reconstructionOriginal Research · 2026
2Serplulimab combined with gemcitabine, nab-paclitaxel, and stereotactic body radiotherapy as first-line treatment for metastatic pancreatic adenocarcinoma: a multicentre, single-arm, phase II trial2025
3A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors2024 · 14 citations
4Abstract 1184: Combination pembrolizumab and radiotherapy induces anti-tumor immune responses in immunologically-cold non-small cell lung cancer2024
5Complete response to pembrolizumab in radiation-induced undifferentiated pleomorphic sarcoma of the face: A case report and review of the literatureCase Report · 2026

More from Clinical Case Reports

More from University of Bari Aldo Moro